This work is licensed under a Creative Commons Attribution 4.0 International License.
Alyteserin-2a [G3K]
General Information
DCTPep ID DCTPep02088
Peptide Name Alyteserin-2a [G3K]
Sequence ILKKLLSTAAGLLSNL
Sequence Length 16
UniProt ID Not available
PubChem CID Not available
Origin Synthetic (Derived from Alyteserin-2a)
Type Synthetic peptide
Classification
ACP Tumor active peptide
Activity Information
| Cell Line | Disease | Activity | Assay | Testing Time | Literature |
|---|---|---|---|---|---|
| A549 | Lung adenocarcinoma | LC50=100 μM | CellTiter-Glo Luminescent Cell Viability assay | 24 h | 1 |
Hemolytic Activity Human erythrocytes: 50% Hemolysis=105 µM
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure DCTPep02088
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C76H139N19O21
Absent amino acids CDEFHMPQRVWY
Theoretical pI 10.00
Acidic residues 0
Basic residues 2
Polar residues 5
Molecular weight (Average) 1655.05
Molecular weight (Monoisotopic) 1654.04
Common amino acids L
Net charge 2
Instability index (II) 10.8
Aliphatic index 183.12
Grand average of hydropathicity (GRAVY) 1.056
Half Life
20 hours (mammalian reticulocytes, in vitro).
30 min (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).
Extinction coefficients
Should not be visible by UV spectrophotometry.
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 22965637
Title Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent
Year 2013
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_4360
This work is licensed under a Creative Commons Attribution 4.0 International License.